The growth in the consumption of these medicines may be explained by an increasing number of people diagnosed with type 2 diabetes mellitus and by the fact that nonglycemic-controlled type 2 diabetes mellitus patients started being treated with an increasing number of noninsulin antidiabetic drugs or even accepting the use of insulin. The gene discussed is INS; the disease is diabetes mellitus.